oral semaglutide cardiovascular benefit in Cardiometabolic Diseases: SELECTing the Target Population Cardiovascular Outcomes Associated with Semaglutide

V., Popuchiev, V

WEGOVY (semaglutide) injection Wegovy is a once-weekly injectable prescription medicine recently FDA-approved to help adults with obesityor excess weight along with weight-related medical problemslose weight

India supplies more than half of Africa's generic medicines, and cheaper semaglutide could become a lifeline for countries where obesity is rising rapidly, but treatment remains unaffordable

It also REALLY helps with fatigue and irritability, I have energy

These cardioprotective properties appear to be mediated at least partly through CD36 receptor binding, independent of the GHS-R1a/GH pathway, and represent one of the most promising avenues for future GHRP-6 research